The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cue Biopharma Inc (NASDAQ: CUE) closed the day trading at $1.50 down -11.76% from the previous closing price of $1.70. In other words, the price has decreased by -$11.76 from its previous closing price. On the day, 0.53 million shares were traded. CUE stock price reached its highest trading level at $1.84 during the session, while it also had its lowest trading level at $1.46.
Ratios:
For a better understanding of CUE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.06 and its Current Ratio is at 2.06. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 13, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On November 21, 2022, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $7.Piper Sandler initiated its Overweight rating on November 21, 2022, with a $7 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CUE now has a Market Capitalization of 101751000 and an Enterprise Value of 54198976. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.88 while its Price-to-Book (P/B) ratio in mrq is 3.37. Its current Enterprise Value per Revenue stands at 6.534 whereas that against EBITDA is -1.136.
Stock Price History:
Over the past 52 weeks, CUE has reached a high of $3.25, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is 35.34%, while the 200-Day Moving Average is calculated to be 6.30%.
Shares Statistics:
Over the past 3-months, CUE traded about 680.83K shares per day on average, while over the past 10 days, CUE traded about 675100 shares per day. A total of 60.21M shares are outstanding, with a floating share count of 59.65M. Insiders hold about 0.92% of the company’s shares, while institutions hold 27.43% stake in the company. Shares short for CUE as of 1730332800 were 1780964 with a Short Ratio of 2.62, compared to 1727654400 on 3800384. Therefore, it implies a Short% of Shares Outstanding of 1780964 and a Short% of Float of 2.98.
